Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
European Journal of Cancer & Clinical Oncology
|
November 1, 1984
An EORTC phase II study of mitoxantrone in solid tumors and lymphomas
R De Jager, P Cappelaere, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group
J P Guastalla, J B Vermorken, J A Wils, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|
April 30, 2025
Reducing Readmission for Sepsis by Improving Risk Prediction Algorithms
Valerie J Renard, Parisa Farahani, Leanne M Boehm, et al.
Investigational New Drugs
|
January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma
S B Kaye, M Clavel, P Dodion, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|
August 31, 2025
Response
Valerie J Renard, Parisa Farahani, Amy L B Frazier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial
J Jassem, T Pieńkowski, A Płuzańska, et al.
The New England Journal of Medicine
|
March 9, 1995
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer
M E van der Burg, M van Lent, M Buyse, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1983
Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group
R De Jager, P Siegenthaler, F Cavalli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents
G Schwartsmann, J Wanders, I J Koier, et al.
European Journal of Cancer
|
December 1, 1977
The E.O.R.T.C. Data Center
M Staquet, R Sylvester, D Machin, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
European Journal of Cancer & Clinical Oncology
|
November 1, 1984
An EORTC phase II study of mitoxantrone in solid tumors and lymphomas
R De Jager, P Cappelaere, J P Armand, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group
J P Guastalla, J B Vermorken, J A Wils, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|
April 30, 2025
Reducing Readmission for Sepsis by Improving Risk Prediction Algorithms
Valerie J Renard, Parisa Farahani, Leanne M Boehm, et al.
Investigational New Drugs
|
January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma
S B Kaye, M Clavel, P Dodion, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|
August 31, 2025
Response
Valerie J Renard, Parisa Farahani, Amy L B Frazier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial
J Jassem, T Pieńkowski, A Płuzańska, et al.
The New England Journal of Medicine
|
March 9, 1995
The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer
M E van der Burg, M van Lent, M Buyse, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1983
Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group
R De Jager, P Siegenthaler, F Cavalli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents
G Schwartsmann, J Wanders, I J Koier, et al.
European Journal of Cancer
|
December 1, 1977
The E.O.R.T.C. Data Center
M Staquet, R Sylvester, D Machin, et al.
Page
of 10